CTRI/2023/04/051549Not yet recruitingUnknown
Randomized open label controlled clinical trial to evaluate an effect of Jivanti Ghrita eye drops in Dry Eye syndrome.
Center for Research and Development0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Gharsha(Foreign body sensation),
- •Samdahan(Burning),
- •Upadeha(Mucous discharge),
- •Avil Darshana(Blurring of vision), Vishushkatva(Dryness),
- •Toda,Bhed,Shool( Pain),
- •Kunita Vartma(Narrowing of Palpebral aperture due to Photophobia).
Exclusion Criteria
- •Patient presenting with dry eye complicated with infective conjunctivitis.
- •Patient presenting with disorders of lid-globe apposition.
- •Patient suffering from specific ocular or systemic diseases
Investigators
Similar Trials
Completed
Phase 4
Evaluation of the effect of Allopurionol on the progression of Chronic Kidney Disease of Uncertain etiology in Sri LankaChronic Kidney Disease of uncertain etiology (CKD-u)SLCTR/2017/026ational Research Council, Sri Lanka
Not yet recruiting
Phase 2
Study the effect of Ayurvedic formulation in kidney stoneCTRI/2023/11/060093Ayurved Seva Sangh Ayurved Mahavidyalaya
Active, not recruiting
Phase 1
The efficacy and the safety of Vitamin D3 30,000 IU for loading dose schedulesVitamin-D deficient patientsMedDRA version: 20.0Level: PTClassification code 10047626Term: Vitamin D deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2018-000508-40-HUPharma Patent Kft.96
Completed
Phase 2
An open label Randomized Controlled Clinical trial to Evaluate the Safety and Efficacy of selected Siddha formulations in patients diagnosed with COVID-19CTRI/2020/06/025768ational Institute of Siddha215
Active, not recruiting
Phase 1
Clinical Trial of vedolizumab versus conventional treatment for Checkpoint Inhibitor induced ColitisImmune check point inhibitor induced colitisMedDRA version: 22.0Level: LLTClassification code 10082455Term: Immune-mediated colitisSystem Organ Class: 100000004856EUCTR2020-005793-10-DKJakob Benedict Seidelin76